MedPath

Comparison of the effectiveness of the three methods: healing with dry amniotic dressing, dressing with platelet derived growth factor, and conventional surgical debridement on the improvement of diabetic foot ulcer

Phase 2
Recruiting
Conditions
Diabetic foot ulcer.
Type 2 diabetes mellitus with foot ulcer
E11.621
Registration Number
IRCT20120215009014N352
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
123
Inclusion Criteria

Age of 18 to 70 years,
Diabetic foot ulcer with dimension between 1 and 10 cm,
Level 1 or 2 based on Vegner scale,
HbA1c less than 8,
Suitable tissue circulation,

Exclusion Criteria

Pregnancy or breastfeeding,
Osteomyelitis,
Malnutrition,
Chemotherapy or radiotherapy,
Malignancy,
Autoimmune diseases,
Renal diseases needing dialysis,
Immunosuppressive drugs

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improve diabetic foot ulcers. Timepoint: In weeks 4, 6, 8 and 10 after the intervention. Method of measurement: With clinical examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath